Posts

Showing posts with the label Neutropenia

Neutropenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Neutrophils play a crucial role in the immune system by ingesting, destroying, and digesting invading microorganisms, encompassing fungi and bacteria. Failure to fulfill this role results in immunodeficiency, characterized primarily by recurrent infections. A standard circulating neutrophil count is above 1.5 x 10/L. Neutropenia, defined as an absolute neutrophil count (ANC) below 1500 per microliter (1500/microL), can be categorized as asymptomatic (mild), moderate, or severe, indicating the risk of infection. The severity of neutropenia is stratified as follows: ·        Mild: 1000 to 1500/mcL (1 to 1.5 × 10^9/L) ·        Moderate: 500 to 1000/mcL (0.5 to 1 × 10^9/L) ·        Severe: < 500/mcL (< 0.5 × 10^9/L) Primary defects in neutrophil function involve failures in adhering to endothelial cells, abnormal chemotaxis, inadequate bacterial ingestion and killing, insufficient p...

Neutropenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Neutrophils play a crucial role in the immune system by ingesting, destroying, and digesting invading microorganisms, encompassing fungi and bacteria. Failure to fulfill this role results in immunodeficiency, characterized primarily by recurrent infections. A standard circulating neutrophil count is above 1.5 x 10/L. Neutropenia, defined as an absolute neutrophil count (ANC) below 1500 per microliter (1500/microL), can be categorized as asymptomatic (mild), moderate, or severe, indicating the risk of infection. The severity of neutropenia is stratified as follows: 1.        Mild: 1000 to 1500/mcL (1 to 1.5 × 10^9/L) 2.        Moderate: 500 to 1000/mcL (0.5 to 1 × 10^9/L) 3.        Severe: < 500/mcL (< 0.5 × 10^9/L) Primary defects in neutrophil function involve failures in adhering to endothelial cells, abnormal chemotaxis, inadequate bacterial ingestion and killing, insufficien...

Neutropenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Neutropenia is defined as an absolute neutrophil count (ANC) of less than 1500 per microliter (1500/microL). Severe neutropenia is defined as less than 500 per microliter (500/microL). The causes of primary defects of neutrophil function include failure of the following: Adhere to endothelial cells, Migrate into inflammation sites (abnormal chemotaxis), Ingest and kill bacteria, Produce microbicidal compounds to kill fungi and other pathogens, Form phagolysosomes, Make high concentrations of toxic reactive oxygen species. ·        In the United States, the prevalence of neutropenia was 0.38% among Mexican-Americans, 0.79% among whites, and 4.5% among black participants. Thelansis’s “Neutropenia Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient sh...

Neutropenia – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
  Neutropenia is defined as an absolute neutrophil count (ANC) of less than 1500 per microliter (1500/microL). Severe neutropenia is defined as less than 500 per microliter (500/microL).   Epidemiology- The causes of primary defects of neutrophil function include failure of the following: Adhere to endothelial cells, Migrate into inflammation sites (abnormal chemotaxis), Ingest and kill bacteria, Produce microbicidal compounds to kill fungi and other pathogens, Form phagolysosomes, Make high concentrations of toxic reactive oxygen species. Low levels of neutrophils may be due to hypoplastic bone marrow, an infection, radiation exposure, tumour infiltration of the bone marrow, myelofibrosis, prolonged exposure to a drug, or a hereditary disorder. Congenital neutropenia or Kostmann syndrome is acquired in an autosomal recessive fashion. Drugs are known to cause neutropenia to include: Quinidine Aminopyrine, Cephalosporin, Sulfonamides, Hydralazine, Penicillins, Heavy m...